HSPX:LSE:LSE-HSBC S&P 500 UCITS ETF (GBX)

ETF | Others |

Last Closing

USD 4389.1

Change

+39.10 (+0.90)%

Market Cap

N/A

Volume

0.08M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-4.00 (-2.15%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+4.37 (+3.69%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.08 (+0.57%)

USD 572.76B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.11 (-0.59%)

USD 572.76B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.45 (-0.64%)

USD 266.08B
0QZO:LSE 0QZO

-0.45 (-0.48%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

-0.19 (-0.60%)

USD 208.06B
0QZ3:LSE Qualcomm Inc.

-1.12 (-0.67%)

USD 202.26B
0R24:LSE Intel Corp.

-0.67 (-2.92%)

USD 196.14B

ETFs Containing HSPX:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.37% 76% C+ 74% C
Dividend Return 0.01% 12% F 17% F
Total Return 15.38% 75% C 73% C
Trailing 12 Months  
Capital Gain 24.90% 69% C- 69% C-
Dividend Return 0.01% 13% F 15% F
Total Return 24.91% 68% D+ 68% D+
Trailing 5 Years  
Capital Gain 83.31% 87% B+ 87% B+
Dividend Return 0.05% 16% F 13% F
Total Return 83.36% 86% B+ 86% B+
Average Annual (5 Year Horizon)  
Capital Gain 13.76% N/A N/A 78% C+
Dividend Return 13.76% N/A N/A 77% C+
Total Return 0.01% N/A N/A 13% F
Risk Return Profile  
Volatility (Standard Deviation) 11.13% N/A N/A 76% C+
Risk Adjusted Return 123.65% N/A N/A 99% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike